Literature DB >> 19682741

Dual modulation of CNS voltage-gated calcium channels by cannabinoids: Focus on CB1 receptor-independent effects.

Natalia Lozovaya1, Rogier Min, Vera Tsintsadze, Nail Burnashev.   

Abstract

The neuromodulatory effects of cannabinoids in the central nervous system have mainly been associated with G-protein coupled cannabinoid receptor (CB1R) mediated inhibition of voltage-gated calcium channels (VGCCs). Numerous studies show, however, that cannabinoids can also modulate VGCCs independent of CB1R activation. Nevertheless, despite the fact that endocannabinoids have a nearly equal efficacy for direct and CB1R-mediated effects on VGCC, the role of the direct cannabinoid-VGCC interaction has been largely underestimated. In this review, we summarize recent studies on the modulation of different types of VGCCs by cannabinoids, highlight the evidence for and implications of the CB1R-independent modulation, and put forward the concept, that direct interaction of cannabinoids and VGCCs is as important in regulation of VGCCs function as the CB1R-mediated effects.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682741     DOI: 10.1016/j.ceca.2009.07.007

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  11 in total

1.  Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocannabinol in humans discriminating [INCREMENT]9-tetrahydrocannabinol.

Authors:  Joshua A Lile; Michael J Wesley; Thomas H Kelly; Lon R Hays
Journal:  Behav Pharmacol       Date:  2016-04       Impact factor: 2.293

2.  Effects of the endogenous cannabinoid anandamide on voltage-dependent sodium and calcium channels in rat ventricular myocytes.

Authors:  Lina T Al Kury; Oleg I Voitychuk; Keun-Hang Susan Yang; Faisal T Thayyullathil; Petro Doroshenko; Ali M Ramez; Yaroslav M Shuba; Sehamuddin Galadari; Frank Christopher Howarth; Murat Oz
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

3.  Cannabis constituents modulate δ9-tetrahydrocannabinol-induced hyperphagia in rats.

Authors:  Jonathan A Farrimond; Andrew J Hill; Benjamin J Whalley; Claire M Williams
Journal:  Psychopharmacology (Berl)       Date:  2010-03-27       Impact factor: 4.530

4.  Cell type-specific regulation of inhibition via cannabinoid type 1 receptors in rat neocortex.

Authors:  Claire L De-May; Afia B Ali
Journal:  J Neurophysiol       Date:  2012-10-10       Impact factor: 2.714

5.  L-type calcium channel mediates anticonvulsant effect of cannabinoids in acute and chronic murine models of seizure.

Authors:  Nima Naderi; Leila Ahmad-Molaei; Ali Mazar-Atabaki; Abdolaziz Ronaghi; Zahra Shirazi-zand; Seyed Mehrdad Motiei-Langroudi; Somayeh Eslahkar
Journal:  Neurochem Res       Date:  2011-09-18       Impact factor: 3.996

Review 6.  The endocannabinoid system in cardiovascular function: novel insights and clinical implications.

Authors:  Salvador Sierra; Natasha Luquin; Judith Navarro-Otano
Journal:  Clin Auton Res       Date:  2017-12-08       Impact factor: 4.435

7.  BDNF-induced endocannabinoid release modulates neocortical glutamatergic neurotransmission.

Authors:  Mason L Yeh; Rajamani Selvam; Eric S Levine
Journal:  Synapse       Date:  2017-02-11       Impact factor: 2.562

8.  The du(2J) mouse model of ataxia and absence epilepsy has deficient cannabinoid CB₁ receptor-mediated signalling.

Authors:  Xiaowei Wang; Benjamin J Whalley; Gary J Stephens
Journal:  J Physiol       Date:  2013-06-03       Impact factor: 5.182

9.  (-)-Trans-Δ9-Tetrahydrocannabinol-Like Discriminative-Stimulus Effects of Gabapentin in Cannabis Users.

Authors:  Takato Hiranita
Journal:  J Alcohol Drug Depend       Date:  2016-02-10

Review 10.  Dynamic regulation of the endocannabinoid system: implications for analgesia.

Authors:  Devi Rani Sagar; A Gemma Gaw; Bright N Okine; Stephen G Woodhams; Amy Wong; David A Kendall; Victoria Chapman
Journal:  Mol Pain       Date:  2009-10-08       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.